Published in Genes Chromosomes Cancer on May 01, 2005
Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1. Blood (2008) 2.08
Erythrocyte sedimentation rate measurements by TEST 1 better reflect inflammation than do those by the Westergren method in patients with malignancy, autoimmune disease, or infection. Am J Clin Pathol (2009) 2.05
A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Genes Chromosomes Cancer (2003) 2.01
A study on 289 consecutive Korean patients with acute leukaemias revealed fluorescence in situ hybridization detects the MLL translocation without cytogenetic evidence both initially and during follow-up. Br J Haematol (2002) 1.52
Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea. Thromb Res (2008) 1.48
A meta-analysis of the effects of interleukin-6 -174 G>C genetic polymorphism on acute graft-versus-host disease susceptibility. Clin Ther (2012) 1.41
Multiple myeloma with myelomatous pleural effusion: a case report and review of the literature. Acta Haematol (2008) 1.35
Computer-aided diagnosis of solid breast nodules: use of an artificial neural network based on multiple sonographic features. IEEE Trans Med Imaging (2004) 1.33
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines. Cancer Lett (2008) 1.23
Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung. Lung Cancer (2007) 1.23
Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med (2009) 1.21
Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. Blood (2007) 1.18
Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genet Cytogenet (2009) 1.15
Recent advances in miniaturized microfluidic flow cytometry for clinical use. Electrophoresis (2007) 1.15
AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene (2004) 1.14
Ionic circuits based on polyelectrolyte diodes on a microchip. Angew Chem Int Ed Engl (2009) 1.14
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study. Am J Hematol (2014) 1.13
Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets. Ann Hematol (2010) 1.11
Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. Mol Oncol (2008) 1.11
Nanoporous platinum solid-state reference electrode with layer-by-layer polyelectrolyte junction for pH sensing chip. Lab Chip (2010) 1.10
Plasmonic nanostructures for nano-scale bio-sensing. Sensors (Basel) (2011) 1.05
Nonenzymatic glucose detection using mesoporous platinum. Anal Chem (2003) 1.05
Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Biol Blood Marrow Transplant (2009) 1.03
Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype. Int J Hematol (2009) 1.03
Near-infrared emitting polymer nanogels for efficient sentinel lymph node mapping. ACS Nano (2012) 1.02
Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract. Exp Mol Med (2009) 1.00
Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci (2010) 0.99
Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways. Int J Oncol (2008) 0.98
Slope of emphysema index: an objective descriptor of regional heterogeneity of emphysema and an independent determinant of pulmonary function. AJR Am J Roentgenol (2010) 0.96
Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party. Int J Hematol (2010) 0.96
A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome. Haematologica (2011) 0.96
Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Am J Hematol (2002) 0.95
IT-based diagnostic instrumentation systems for personalized healthcare services. Stud Health Technol Inform (2005) 0.93
Electrochemical nanoneedle biosensor based on multiwall carbon nanotube. Anal Chem (2006) 0.92
Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome. Biol Blood Marrow Transplant (2009) 0.92
Feasibility of automated quantification of regional disease patterns depicted on high-resolution computed tomography in patients with various diffuse lung diseases. Korean J Radiol (2009) 0.92
Prognostic implications of the immunophenotype in biphenotypic acute leukemia. Leuk Lymphoma (2008) 0.92
Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol (2003) 0.91
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leuk Lymphoma (2006) 0.91
Differentiation of recently infarcted myocardium from chronic myocardial scar: the value of contrast-enhanced SSFP-based cine MR imaging. Korean J Radiol (2006) 0.91
Small (<or= 2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI. AJR Am J Roentgenol (2004) 0.91
Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients. Med Oncol (2011) 0.91
The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. Biomaterials (2011) 0.91
Quantitative assessment of change in regional disease patterns on serial HRCT of fibrotic interstitial pneumonia with texture-based automated quantification system. Eur Radiol (2012) 0.91
Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. Int J Oncol (2003) 0.89
A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma. Int J Hematol (2006) 0.89
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). PLoS One (2008) 0.89
Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target. Clin Exp Metastasis (2007) 0.89
Evaluation of the novel near-infrared fluorescence tracers pullulan polymer nanogel and indocyanine green/γ-glutamic acid complex for sentinel lymph node navigation surgery in large animal models. Gastric Cancer (2014) 0.89
Cytometry and velocimetry on a microfluidic chip using polyelectrolytic salt bridges. Anal Chem (2005) 0.88
TNF α mediated IL-6 secretion is regulated by JAK/STAT pathway but not by MEK phosphorylation and AKT phosphorylation in U266 multiple myeloma cells. Biomed Res Int (2013) 0.88
A portable microfluidic flow cytometer based on simultaneous detection of impedance and fluorescence. Biosens Bioelectron (2009) 0.88
Clinical dissection of multicentric Castleman disease. Leuk Lymphoma (2011) 0.88
Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia. Am J Hematol (2011) 0.88
Computer-aided diagnosis of solid breast nodules on ultrasound with digital image processing and artificial neural network. Conf Proc IEEE Eng Med Biol Soc (2004) 0.88
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Haematologica (2007) 0.88
Multicenter study of pain and its management in patients with advanced cancer in Korea. J Pain Symptom Manage (2003) 0.87
Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients. Thromb Res (2002) 0.87
PKC inhibitors RO 31-8220 and Gö 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation. BMB Rep (2011) 0.87
Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes. Br J Haematol (2013) 0.87
Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia. Korean J Hematol (2011) 0.87
Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis. Int J Oncol (2003) 0.87
CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease. Respir Med (2008) 0.86
Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide. Eur J Haematol (2014) 0.86
Shear-wave elastographic features of breast cancers: comparison with mechanical elasticity and histopathologic characteristics. Invest Radiol (2014) 0.86
Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia. Leuk Res (2005) 0.86
A label-free DC impedance-based microcytometer for circulating rare cancer cell counting. Lab Chip (2013) 0.86
Association of human leukocyte antigen-DRB1 alleles with disease susceptibility and severity of aplastic anemia in Korean patients. Hum Immunol (2008) 0.86
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib. Ann Hematol (2010) 0.86
Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients. Hum Immunol (2010) 0.86
Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction. Br J Haematol (2009) 0.86